antigen

(redirected from cancer antigen 125)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to cancer antigen 125: Cancer antigen 15-3, Cancer antigen 19-9
  • noun

Words related to antigen

any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)

References in periodicals archive ?
Food and Drug Administration for diagnostic use, is designed to detect cancer antigen 125 (CA 125) levels in human serum and plasma.
Large-scale screening for ovarian cancer with a combination of transvaginal ultrasound and cancer antigen 125 is a feasible strategy that can accurately identify early cancers, a large U.
Ovarian cancer growth-related and cancer antigen 125 (CA-125)-related parameters from the published literature were used to "prime the model," thereby establishing the "baseline parameters" for the earliest detection time or the smallest tumor diameter or volume that could be detected by current CA-125 ELISA assays.
The test utilizes five well-established biomarkers -- Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), beta2-Microglobulin (beta2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) -- and proprietary software to determine the likelihood of malignancy in women with ovarian mass for whom surgery is planned.
The Risk of Ovarian Malignancy Algorithm (ROMA) stratifies women at high or low risk for epithelial ovarian cancer based on menopausal status and preoperative serum levels of human epididymis protein 4 (HE4) and cancer antigen 125 (CA 125).
The Risk of Ovarian Malignancy Algorithm (ROMA) stratifies women as being at high or low risk for epithelial ovarian cancer based on menopausal status and preoperative serum levels of two biomarkers: human epididymis protein 4 (HE4) and cancer antigen 125 (CA 125).
The test utilizes five well-established biomarkers - Transthyretin (TT or prealbumin), Apolipoprotein A-1 (Apo A-1), Beta 2-Microglobulin (Beta 2M), Transferrin (Tfr) and Cancer Antigen 125 (CA 125 II) - and a proprietary FDA-cleared software device to determine the likelihood of malignancy in women with pelvic mass for whom surgery is planned.
San Antonio -- Elevated cancer antigen 125 levels measured after surgery but before chemotherapy are an independent prognostic indicator of recurrence and worse survival in women with high-risk, early-stage epithelial ovarian cancer, according to results of a Gynecologic Oncology Group study.